212 related articles for article (PubMed ID: 17974941)
1. Prescription OxyContin abuse among patients entering addiction treatment.
Carise D; Dugosh KL; McLellan AT; Camilleri A; Woody GE; Lynch KG
Am J Psychiatry; 2007 Nov; 164(11):1750-6. PubMed ID: 17974941
[TBL] [Abstract][Full Text] [Related]
2. An exploratory study of OxyContin use among individuals with substance use disorders.
Levy MS
J Psychoactive Drugs; 2007 Sep; 39(3):271-6. PubMed ID: 18159780
[TBL] [Abstract][Full Text] [Related]
3. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
4. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
Cassidy TA; Thorley E; Black RA; DeVeaugh-Geiss A; Butler SF; Coplan P
J Opioid Manag; 2017; 13(6):425-440. PubMed ID: 29308589
[TBL] [Abstract][Full Text] [Related]
5. Seeking drug treatment for OxyContin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in Kentucky.
Hays L; Kirsh KL; Passik SD
J Natl Compr Canc Netw; 2003 Jul; 1(3):423-8. PubMed ID: 19761073
[TBL] [Abstract][Full Text] [Related]
6. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
Cicero TJ; Ellis MS
JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
[TBL] [Abstract][Full Text] [Related]
7. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
8. OxyContin use and misuse in three populations: substance abuse patients, pain patients, and criminal justice participants.
Wunsch MJ; Cropsey KL; Campbell ED; Knisely JS
J Opioid Manag; 2008; 4(2):73-9. PubMed ID: 18557163
[TBL] [Abstract][Full Text] [Related]
9. A profile of OxyContin addiction.
Hays LR
J Addict Dis; 2004; 23(4):1-9. PubMed ID: 15339710
[TBL] [Abstract][Full Text] [Related]
10. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.
Knisely JS; Wunsch MJ; Cropsey KL; Campbell ED
J Subst Abuse Treat; 2008 Dec; 35(4):380-6. PubMed ID: 18657935
[TBL] [Abstract][Full Text] [Related]
11. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
Cheng HG; Coplan PM
Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
[TBL] [Abstract][Full Text] [Related]
12. Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program.
Vosburg SK; Haynes C; Besharat A; Green JL
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1044-1052. PubMed ID: 28653782
[TBL] [Abstract][Full Text] [Related]
13. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.
Martins SS; Storr CL; Zhu H; Chilcoat HD
Drug Alcohol Depend; 2009 Jan; 99(1-3):58-67. PubMed ID: 18706774
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
[TBL] [Abstract][Full Text] [Related]
15. Non-medical use of OxyContin Tablets in the United States.
Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
[TBL] [Abstract][Full Text] [Related]
16. Impact of abuse-deterrent OxyContin on prescription opioid utilization.
Hwang CS; Chang HY; Alexander GC
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):197-204. PubMed ID: 25393216
[TBL] [Abstract][Full Text] [Related]
17. Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone.
Miller NS; Greenfeld A
Am J Ther; 2004; 11(1):26-32. PubMed ID: 14704593
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
Manchikanti L; Singh A
Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
[TBL] [Abstract][Full Text] [Related]
19. Toward primary prevention of extra-medical OxyContin® use among young people.
Deandrea DC; Troost JP; Anthony JC
Prev Med; 2013 Sep; 57(3):244-6. PubMed ID: 23701847
[TBL] [Abstract][Full Text] [Related]
20. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
